Nonhuman Primates Are Protected from Smallpox Virus or Monkeypox Virus Challenges by the Antiviral Drug ST-246
- 1 June 2009
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 53 (6) , 2620-2625
- https://doi.org/10.1128/aac.00021-09
Abstract
ST-246, a potent orthopoxvirus egress inhibitor, is safe and effective at preventing disease and death in studies of small-animal models involving challenge by several different pathogenic poxviruses. In this report, the antiviral efficacy of ST-246 in treatment of nonhuman primates infected with variola virus or monkeypox virus was assessed. The data indicate that oral dosing once per day with ST-246 protects animals from poxvirus disease, as measured by reductions in viral load and numbers of lesions and enhancement of survival.Keywords
This publication has 23 references indexed in Scilit:
- Single-Dose Safety and Pharmacokinetics of ST-246, a Novel Orthopoxvirus Egress InhibitorAntimicrobial Agents and Chemotherapy, 2008
- Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit modelAntiviral Research, 2008
- Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus disseminationVaccine, 2007
- Synergistic Efficacy of the Combination of ST-246 with CMX001 against OrthopoxvirusesAntimicrobial Agents and Chemotherapy, 2007
- Efficacy of Delayed Treatment with ST-246 Given Orally against Systemic Orthopoxvirus Infections in MiceAntimicrobial Agents and Chemotherapy, 2007
- Clinical Characteristics of Human Monkeypox, and Risk Factors for Severe DiseaseClinical Infectious Diseases, 2005
- Individual Reference Intervals of Hematological and Serum Biochemical Parameters in Cynomolgus MonkeysInternational Journal of Toxicology, 2005
- Characterization of Acute-Phase Humoral Immunity to Monkeypox: Use of Immunoglobulin M Enzyme-Linked Immunosorbent Assay for Detection of Monkeypox Infection during the 2003 North American OutbreakClinical and Vaccine Immunology, 2005
- Outbreak of Human Monkeypox, Democratic Republic of Congo, 1996 to 1997Emerging Infectious Diseases, 2001
- Outbreak of Human Monkeypox, Democratic Republic of Congo, 1996 to 1997Emerging Infectious Diseases, 2001